- call +1-201-465-4211
- email sales@mrinsights.biz
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Scope of the Report:
This report focuses on the Gastrointestinal Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Gastrointestinal Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market Segment by Applications, can be divided into
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
There are 15 Chapters to deeply display the global Gastrointestinal Drugs market.
Chapter 1, to describe Gastrointestinal Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Gastrointestinal Drugs, with sales, revenue, and price of Gastrointestinal Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Gastrointestinal Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Gastrointestinal Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Gastrointestinal Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Prescription Gastrointestinal Drug
1.2.2 OTC Gastrointestinal Drug
1.3 Market Analysis by Applications
1.3.1 Chronic Gastritis
1.3.2 Functional Dyspepsia
1.3.3 Peptic Ulcer
1.3.4 Acute Gastroenteritis
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Gastrointestinal Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Gastrointestinal Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Gastrointestinal Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Gastrointestinal Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Gastrointestinal Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva
2.6.1 Business Overview
2.6.2 Gastrointestinal Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Zeria（Tillotts）
2.7.1 Business Overview
2.7.2 Gastrointestinal Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Zeria（Tillotts） Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Perrigo
2.8.1 Business Overview
2.8.2 Gastrointestinal Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Perrigo Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Gastrointestinal Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Purdue Pharma
2.10.1 Business Overview
2.10.2 Gastrointestinal Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 C.B. Fleet
2.11.1 Business Overview
2.11.2 Gastrointestinal Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Abbott
2.12.1 Business Overview
2.12.2 Gastrointestinal Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Abbott Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Jiangzhong
2.13.1 Business Overview
2.13.2 Gastrointestinal Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Xian-Janssen
2.14.1 Business Overview
2.14.2 Gastrointestinal Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Gastrointestinal Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Gastrointestinal Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Gastrointestinal Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastrointestinal Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Gastrointestinal Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Gastrointestinal Drugs Market Analysis by Regions
4.1 Global Gastrointestinal Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Gastrointestinal Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Gastrointestinal Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
4.5 South America Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
5 North America Gastrointestinal Drugs by Countries
5.1 North America Gastrointestinal Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Gastrointestinal Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Gastrointestinal Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
6 Europe Gastrointestinal Drugs by Countries
6.1 Europe Gastrointestinal Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Gastrointestinal Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Gastrointestinal Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
6.3 UK Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
6.4 France Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Gastrointestinal Drugs by Countries
7.1 Asia-Pacific Gastrointestinal Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Gastrointestinal Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Gastrointestinal Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
7.5 India Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
8 South America Gastrointestinal Drugs by Countries
8.1 South America Gastrointestinal Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Gastrointestinal Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Gastrointestinal Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Gastrointestinal Drugs by Countries
9.1 Middle East and Africa Gastrointestinal Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Gastrointestinal Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Gastrointestinal Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Gastrointestinal Drugs Sales and Growth Rate (2013-2018)
10 Global Gastrointestinal Drugs Market Segment by Type
10.1 Global Gastrointestinal Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Gastrointestinal Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2013-2018)
10.2 Prescription Gastrointestinal Drug Sales Growth and Price
10.2.1 Global Prescription Gastrointestinal Drug Sales Growth (2013-2018)
10.2.2 Global Prescription Gastrointestinal Drug Price (2013-2018)
10.3 OTC Gastrointestinal Drug Sales Growth and Price
10.3.1 Global OTC Gastrointestinal Drug Sales Growth (2013-2018)
10.3.2 Global OTC Gastrointestinal Drug Price (2013-2018)
11 Global Gastrointestinal Drugs Market Segment by Application
11.1 Global Gastrointestinal Drugs Sales Market Share by Application (2013-2018)
11.2 Chronic Gastritis Sales Growth (2013-2018)
11.3 Functional Dyspepsia Sales Growth (2013-2018)
11.4 Peptic Ulcer Sales Growth (2013-2018)
11.5 Acute Gastroenteritis Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Gastrointestinal Drugs Market Forecast (2018-2023)
12.1 Global Gastrointestinal Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Gastrointestinal Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Gastrointestinal Drugs Market Forecast (2018-2023)
12.2.2 Europe Gastrointestinal Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Gastrointestinal Drugs Market Forecast (2018-2023)
12.2.4 South America Gastrointestinal Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Gastrointestinal Drugs Market Forecast (2018-2023)
12.3 Gastrointestinal Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Gastrointestinal Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Gastrointestinal Drugs Market Share Forecast by Type (2018-2023)
12.4 Gastrointestinal Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Gastrointestinal Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Gastrointestinal Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Gastrointestinal Drugs Picture
Table Product Specifications of Gastrointestinal Drugs
Figure Global Sales Market Share of Gastrointestinal Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
